BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23480014)

  • 1. [Clinical follow up and histological findings of patients with MEN2 treated with prophylactic thyroidectomy].
    Roldán Pérez S; Cabello Laureano R; Fernández-Pineda I; Aspiazu Salinas D; Martínez Criado Y; De Agustín Asensio JC
    Cir Pediatr; 2012 Jul; 25(3):159-62. PubMed ID: 23480014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
    Skinner MA; Wells SA
    Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
    Heizmann O; Haecker FM; Zumsteg U; Müller B; Oberholzer M; Oertli D
    Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung's disease.
    Bütter A; Gagné J; Al-Jazaeri A; Emran MA; Deal C; St-Vil D
    J Pediatr Surg; 2007 Jan; 42(1):203-6. PubMed ID: 17208566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
    Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA
    N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a.
    Gosnell JE; Sywak MS; Sidhu SB; Gough IR; Learoyd DL; Robinson BG; Delbridge LW
    ANZ J Surg; 2006 Jul; 76(7):586-90. PubMed ID: 16813623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
    Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR
    Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
    Cupisti K; Wolf A; Raffel A; Schott M; Miersch D; Yang Q; Eisenberger CF; Röher HD; Knoefel WT
    Ann Surg; 2007 Nov; 246(5):815-21. PubMed ID: 17968174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II].
    Engelbach M; Kunt T; Kann P; Manfras B; Hankeln T; Forst T; Pfützner A; Heerdt S; Walgenbach S; Lehnert H; Beyer J
    Dtsch Med Wochenschr; 2000 Jan; 125(3):37-44. PubMed ID: 10681997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort.
    Febrero B; Rodríguez JM; Ríos A; Segura P; Pérez-Sánchez B; Torregrosa N; Hernández AM; Parrilla P
    Eur J Surg Oncol; 2019 Apr; 45(4):625-630. PubMed ID: 30366876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.
    Yip L; Cote GJ; Shapiro SE; Ayers GD; Herzog CE; Sellin RV; Sherman SI; Gagel RF; Lee JE; Evans DB
    Arch Surg; 2003 Apr; 138(4):409-16; discussion 416. PubMed ID: 12686527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
    Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
    J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Decision making in postoperative incidentally found small C-cell-carcinoma].
    Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT
    Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary thyroid cancer can be cured by prophylactic surgery].
    Wallin G; Bondesson AG; Farnebo LO; Hallengren B; Hamberger B; Jansson S; Nilsson O; Nordenskjöld M; Smeds S; Svensson KA; Wihlborg O; Zedenius J
    Lakartidningen; 2001 Jun; 98(25):3024-8. PubMed ID: 11462876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic thyroidectomy in multiple endocrine neoplasia syndrome].
    Marijuán V; León S; Moreno F; Carles C; Roca A; García-Sala C; Ponce JL
    Cir Pediatr; 2009 Oct; 22(4):189-92. PubMed ID: 20405652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very early prophylactic thyroid surgery for infants with a mutation of the RET proto-oncogene at codon 634: evaluation of the implementation of international guidelines for MEN type 2 in a single centre.
    Piolat C; Dyon JF; Sturm N; Pinson S; Bost M; Jouk PS; Plantaz D; Chabre O
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):118-24. PubMed ID: 16817830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.